Last reviewed · How we verify
Zinc Gluconate 30 MG
At a glance
| Generic name | Zinc Gluconate 30 MG |
|---|---|
| Sponsor | University of Maryland, Baltimore |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection (NA)
- Effect of Zinc on Glucose Homeostasis (PHASE4)
- Zinc Intervention in Elderly for Prevention of Pneumonia (PHASE2, PHASE3)
- A Comparison of the Metabolic Effects of Zinc-Amino Acid (ZnAA) Versus Zinc Gluconate (NA)
- Zinc Supplementation Improves Cardiovascular Morbidity in Patients With Diabetes Mellitus
- The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED) (PHASE2, PHASE3)
- Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults (NA)
- Zinc Supplementation and Behçet's Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zinc Gluconate 30 MG CI brief — competitive landscape report
- Zinc Gluconate 30 MG updates RSS · CI watch RSS
- University of Maryland, Baltimore portfolio CI